Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders

In 2002, the first III generation antipsychotic drug was registered—aripiprazole. Its partial dopaminergic agonism underlies its unique mechanism of action and the potentially beneficial influence on the positive, negative, or cognitive symptoms. Due to its relatively high intrinsic activity, the dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Siwek, Marcin, Wojtasik-Bakalarz, Krzysztof, Krupa, Anna Julia, Chrobak, Adrian Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046771/
https://www.ncbi.nlm.nih.gov/pubmed/36979208
http://dx.doi.org/10.3390/brainsci13030397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046771/
https://www.ncbi.nlm.nih.gov/pubmed/36979208
http://dx.doi.org/10.3390/brainsci13030397

Ejemplares similares